Enliven Therapeutics, Inc. (ELVN) Insider Trading

Name: Enliven Therapeutics, Inc. (ELVN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 5, 2026): J. Scott Garland (Director): Exercise/Conversion of 13,000 shares, $201.1K.

Get alerted when insiders trade ELVN

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta